Trial Profile
Clinical Trials Insight: 700051630
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Dec 2009
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar I disorders; Manic episodes; Schizophrenia
- Focus Pharmacokinetics; Registrational
- Sponsors AstraZeneca
- 10 Dec 2009 New trial record.